Arcadia Biosciences, Inc.·4

Mar 21, 7:18 PM ET

Reiter Sarah 4

4 · Arcadia Biosciences, Inc. · Filed Mar 21, 2018

Insider Transaction Report

Form 4
Period: 2018-03-19
Reiter Sarah
Chief Commercial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2018-03-19+10,00010,000 total
    Exercise: $45.69From: 2019-03-19Exp: 2028-03-19Common Stock (10,000 underlying)
Footnotes (1)
  • [F1]The option vests with respect to 25% of the total securities subject to the option on the first anniversary of the date of award, or March 19, 2019, with the remaining 75% vesting in 36 equal installments beginning March 31, 2019 and ending February 28, 2022, subject to the Participant's continued service.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION